3 results match your criteria: "Dip. Farmacologia Preclinica e Clinica[Affiliation]"
The histamine H3 receptor and eating behavior.
J Pharmacol Exp Ther
January 2011
Dip. Farmacologia Preclinica e Clinica, V.le G. Pieraccini 6, 50139 Firenze, Italy.
Interest in the histaminergic system as a potential target for the treatment of feeding disorders is driven by the unsatisfactory history of the pharmacotherapy of obesity. Eating behavior is regulated by a complex interplay of central neurotransmitter systems, peripheral endocrine stimuli, the circadian rhythm, and environmental cues, all factors that change the behavioral state and alter homeostatic aspects of appetite and energy expenditure. Key factors driving eating behavior are appetite and satiety that are regulated through different mechanisms.
View Article and Find Full Text PDFNeuroWatch.
Neuroreport
January 2002
Sobell Research Department of Motor, Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG; Institute of Neurology, University College of London, London, UK Dip. Farmacologia Preclinica e Clinica, Viale Pieraccini 6, 50139 Firenze, Italy, e-mail address: Institute of Coginitive Neuroscience, University College London, Queen Square, London, UK,
Do ethoxy radicals reduce 3H-nitrendipine binding in rat cardiac membranes?
Pharmacol Res
September 1992
Dip. Farmacologia Preclinica e Clinica, Università di Firenze, Italia.
The incubation of xanthine-oxidase (XOD) with rat cardiac membranes induced the formation of free radicals; they were identified by electron spin resonance spectroscopy (ESR) studies using 0.1 M 5,5-dimethyl-1-pyrroline-1-oxide (DMPO) for spin-trapping. The following DMPO adducts were measured: DMPO-OH, which was produced during the first minute of incubation, DMPO-R radicals, which were present after 4 min of incubation and where the signal intensity remained constant for at least 20 min.
View Article and Find Full Text PDF